| Glucagon-like peptide-2 stimulates S-phase entry of intestinal Lgr5+ stem cells ME Chen, SM Naeini, A Srikrishnaraj, DJ Drucker, Z Fesler, PL Brubaker Cellular and molecular gastroenterology and hepatology 13 (6), 1829-1842, 2022 | 15 | 2022 |
| Trace elements’ contamination of pediatric parenteral nutrition solutions in Canada: a cause for concern A Srikrishnaraj, K Chambers, C South, M Arppe Robertson, L Vresk, ... Journal of Parenteral and Enteral Nutrition 45 (2), 347-356, 2021 | 10 | 2021 |
| Requirement for the intestinal epithelial insulin‐like growth factor‐1 receptor in the intestinal responses to glucagon‐like peptide‐2 and dietary fat MA Markovic, A Srikrishnaraj, D Tsang, PL Brubaker The FASEB Journal 34 (5), 6628-6640, 2020 | 10 | 2020 |
| Complementary and antagonistic effects of combined glucagon‐like peptide‐2 and glucagon‐like peptide‐1 receptor agonist administration on parameters relevant to short bowel … A Srikrishnaraj, H Jeong, PL Brubaker Journal of Parenteral and Enteral Nutrition 46 (6), 1361-1370, 2022 | 6 | 2022 |
| The cytoskeletal transport protein, secretagogin, is essential for diurnal glucagon-like peptide-1 secretion in mice AD Biancolin, A Srikrishnaraj, H Jeong, A Martchenko, PL Brubaker Endocrinology 163 (11), bqac142, 2022 | 4 | 2022 |
| Trace elements' contamination of pediatric parenteral nutrition solutions in Canada: a cause for concern (vol 45, pg 347, 2021) A Srikrishnaraj, K Chambers, C South JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 2022 | | 2022 |
| The Effects of Combined h[Gly2]Glucagon-Like Peptide-2 and Exendin-4 on Parameters Relevant to Short Bowel Syndrome A Srikrishnaraj University of Toronto (Canada), 2021 | | 2021 |
